Single Intralesional Tracer Dose for Radio-Guided Excision of Clinically Occult Breast Cancer and Sentinel Node

2001 ◽  
Vol 8 (10) ◽  
pp. 850-855 ◽  
Author(s):  
P. J. Tanis ◽  
E. E. Deurloo ◽  
R. A. Vald�s Olmos ◽  
E. J.Th. Rutgers ◽  
O. E. Nieweg ◽  
...  
2006 ◽  
Vol 72 (5) ◽  
pp. 397-400 ◽  
Author(s):  
Mehra Golshan ◽  
Beth-Ann Lesnikoski ◽  
Susan Lester

Breast reduction surgery is considered a relative contraindication to a sentinel node biopsy because of the possibility that lymphatics have been interrupted by the procedure. We describe six patients who underwent successful sentinel lymph node biopsy for occult carcinomas detected after breast reduction surgery. A subsequent skin-sparing mastectomy, along with a sentinel lymph node biopsy, was performed. Reconstruction was possible in five of six patients. Sentinel lymph node biopsy should not be considered a contraindication after breast reduction surgery.


2004 ◽  
Vol 43 (01) ◽  
pp. 4-9 ◽  
Author(s):  
A. Bembenek ◽  
H. Büchels ◽  
T. Decker ◽  
J. Dunst ◽  
U. Müllerleile ◽  
...  

SummaryThe international consensus conference from St. Gallen concerning the treatment of early breast cancer concluded in 2003, that sentinel node biopsy was now accepted as method allowing axillary staging in breast cancer. This procedure may avoid complete lymph node dissection in appropriate cases. Since numerous questions associated with the technique are still not defined and the procedure itself is not yet standardized, the German Society of Senology defined the conditions for the routine clinical use of sentinel node biopsy in an interdisciplinary consensus meeting.


Sign in / Sign up

Export Citation Format

Share Document